4Campbell LA, Kuo CC. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis[J]. Nat Rev Microbiol, 2004, 2 (1) : 23-32.
5Campbell LA, NosakaT, RosenfeldME, et al. Tumor necrosis factor alpha plays a role in the acceleration of atheroselerosis by Chlamydia pneumoniae in micen[J]. Infect Immu, 2005, 73 (3): 3164-3165.
6Yavuz MT, Yavuz O, Yazici M, et al. Interaction between Chlamydia pneumoniae seropositivity,inflammation and risk fac- tors for athero-sclerosis in patients with severe coronary stenosis [J]. Scand J Clinic Lab Invest, 2006,66(6) :523-534.
7Boman J, Hammerschlag MR. Chlamydia pneumoniae and Ath- eroselerosis: Critical Assessment of Diagnositie Methods and Relevance to Treatment Studies[J]. Clin Mierobiol Rev, 2002, 15(1): 1-20.
8Naoyuki M, Okimoto N, Yoshida K, et al. Clinical presentationof community-acquired chlamydia pneumoniae Pneumonia in A- dults[J]. CHEST, 2002, 121(6) :1776-1781.
9Kuoppa Y, Boman J, Scott L, et al. Quantitative detection of respiratory Chtamydia pneumoniae infection by Real-Time PCR [J]. Clin Microbiol, 2002, 40(6): 2273-2274.
10Boman J, Seoerberg S, Forsberg J, et al . Chlamydia pneumoniae DNA in peripheral cells inpatients with eardiovasettLar disease blood donors[J]. Infect Dis,1998, 178 (1): High prevalence of blood mononuelear and in middle aged 274-277.
